Insights

Stay abreast of key issues and critical thinking within the European rare disease community.

Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: opportunities and challenges
Improving health equity in Europe’s small countries: how can we remove the barriers to access?
Launching pharmaceuticals in the Nordics: opportunities and challenges
Navigating market access in Sweden
ESG in pharma: meeting requirements in the Nordic region
The power of joint procurement: analysing cross-border initiatives in Benelux and the Nordics
Rare Disease Day: why raising awareness is essential for a fairer future
How early planning leads to successful market access and drug launches in Europe
The EU joint HTA procedure: a gate or barrier for access?
Medical affairs in a digital-first world: benefits and challenges

Press Room

Discover the latest corporate news from AMPS, along with press releases and company announcements.